Jane Street
DNA icon

Jane Street’s Ginkgo Bioworks DNA Stock Holding History

Jane Street’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$322K Buy
+25,096
New +$204K ﹤0.01% 9015
2026
Q1 		– Sell
-181,755
Closed -$1.51M – 11855
2025
Q4 		$1.51M Buy
181,755
+96,736
+114% +$1.04M ﹤0.01% 5327
2025
Q3 		$1.24M Buy
+85,019
New +$1.02M ﹤0.01% 5862
2025
Q2 		– Sell
-69,704
Closed -$540K – 9861
2025
Q1 		$397K Buy
+69,704
New +$710K ﹤0.01% 7282
2024
Q3 		– Sell
-124,533
Closed -$1.25M – 9711
2024
Q2 		$1.67M Buy
124,533
+72,794
+141% +$2.17M ﹤0.01% 4818
2024
Q1 		$2.4M Sell
51,739
-39,541
-43% -$2.05M ﹤0.01% 3811
2023
Q4 		$6.17M Buy
91,280
+50,557
+124% +$3.1M ﹤0.01% 2567
2023
Q3 		$2.95M Sell
40,723
-5,386
-12% -$431K ﹤0.01% 3400
2023
Q2 		$3.43M Buy
46,109
+8,899
+24% +$527K ﹤0.01% 3287
2023
Q1 		$1.98M Buy
37,210
+25,646
+222% +$1.63M ﹤0.01% 3842
2022
Q4 		$782K Sell
11,564
-5,267
-31% -$484K ﹤0.01% 5387
2022
Q3 		$2.1M Buy
16,831
+11,018
+190% +$1.31M ﹤0.01% 4132
2022
Q2 		$553K Buy
5,813
+4,291
+282% +$523K ﹤0.01% 6552
2022
Q1 		$245K Sell
1,522
-2,980
-66% -$580K ﹤0.01% 8717
2021
Q4 		$1.5M Buy
4,502
+4,048
+892% +$1.92M ﹤0.01% 5084
2021
Q3 		$210K Buy
+454
New +$221K ﹤0.01% 8767

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Erste Asset Management
Erste Asset Management Vienna, Austria $13.7B AUM 40.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
J.M. Forbes & Co
J.M. Forbes & Co Boston, Massachusetts $1.33B AUM 21.14% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Jane Street's DNA Position: Q3 2026 in Review

Jane Street opened a new position in Ginkgo Bioworks (DNA) in Q3 2026: 25,096 shares worth $322K. The stake represents ﹤0.01% of the portfolio and ranks #9015 among its holdings. This is a return to the name: Jane Street previously reported a position in DNA as recently as Q4 2025.

Jane Street first reported a position in DNA in Q3 2021 and has held it in 16 quarters since. The position peaked at $6.17M in Q4 2023. 100 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

  • Jane Street held 25,096 shares of Ginkgo Bioworks worth $322K as of Q3 2026.
  • Ginkgo Bioworks was a new Jane Street position in Q3 2026.
  • Ginkgo Bioworks made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #9015 holding.
  • Jane Street first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 16 quarters since.
  • Jane Street's Ginkgo Bioworks position peaked at $6.17M in Q4 2023.
  • 100 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.